TY - JOUR
KW - Adult
KW - Humans
KW - Disease Progression
KW - England
KW - *Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/epidemiology
KW - Quality of Life
KW - *Routinely Collected Health Data
KW - Randomized Controlled Trials as Topic
KW - *Patient Selection
KW - Copd
KW - Rct
KW - Real world evidence
AU - H. Whittaker
AU - A. Torkpour
AU - J. Quint
AD - School of Public Health, Imperial College London, London, UK. h.whittaker@imperial.ac.uk.
Imperial College School of Medicine, Imperial College London, London, UK.
School of Public Health, Imperial College London, London, UK.
AN - 38238769
BT - Respir Res
C2 - PMC10797743
DO - 10.1186/s12931-024-02672-x
DP - NLM
ET - 2024/01/19
LA - eng
M1 - 1
N1 - 1465-993x
Whittaker, Hannah R
Torkpour, Aria
Quint, Jennifer
Journal Article
England
Respir Res. 2024 Jan 18;25(1):43. doi: 10.1186/s12931-024-02672-x.
PY - 2024
SN - 1465-9921 (Print)1465-9921
EP - 43
T2 - Respir Res
TI - Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data
VL - 25
ER -